BORR Q1 2026 Earnings EPS Falls Short of Estimates by a Wide Margin Instil Bio Q1 2026 Earnings EPS Miss as DevelopmentStage Company Reports No Revenue Stock Edges Up ISBA Q1 2026 Earnings Significant EPS Miss Amid Challenging Quarter SOHOB Q2 2025 Earnings Preferred Dividend Coverage Maintained with Reported EPS of 021 IO Biotech Q3 2025 Earnings EPS Beats Estimates by 6067 as Narrowing Losses Highlight Cost Discipline SKWD Q1 2026 Earnings EPS Surges Past Estimates Despite Limited Revenue Disclosure